organization · Reporting owner
Boyalife Investment Fund I, Inc.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nuo Therapeutics, Inc.AURX · Entity 7149 | 10% owner | September 11, 2017 | September 21, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nuo Therapeutics, Inc.
Report date September 11, 2017 · Filed September 21, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.00001 par valueSEC Table I · non-derivative | Direct | 4,900,000 |
Reported balance
After 2017-09-11 transaction · row 1
1 source rowRow 1 · 2017-09-11 · Purchase · Acquired 3,150,000 · Balance 4,900,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2017 Filed Sep 21, 2017 19:45 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock, $.00001 par value | 3,150,000 | $0.22 | $699,930.00 |
DisclosureSEC source: 0001683168-17-002435 · boyalife_frm4.xml · nonDerivative · entry 1 Boyalife Investment Fund I, Inc. · CIK 0001683332 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.